Skip to main content

Table 3 Relationship of CDK5 expression with other clinicopathological variables in adenocarcinoma

From: Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China

Characteristic Total number No. patients, stratified by CDK5 Z P value
Negative (29) Positive (34)
Age     −2.316 0.021a
 ≤44 27 17 (63.0 %) 10 (37.0 %)   
 >44 36 12 (33.3 %) 24 (66.7 %)   
Lymph node metastasis     −1.269 0.205a
 Negative 18 6 (33.3 %) 12 (66.7 %)   
 Positive 45 23 (51.1 %) 22 (48.9 %)   
FIGO stage     −1.269 0.205a
 I–II 45 23 (51.1 %) 22 (48.9 %)   
 III–IV 18 6 (33.3 %) 12 (66.7 %)   
TNM stage
 I 43 23 (53.5 %) 20 (46.5 %) 2.983 0.084a
 II–IV 20 6 (30.0 %) 14 (70.0 %)   
Pathological stage     5.455 0.065b
 I 10 6 (60.0 %) 4 (40.0 %)   
 II 38 20 (52.6 %) 18 (47.4 %)   
 III 15 3 (20.0 %) 12 (80.0 %)   
  1. FIGO International Federation of Gynecology and Obstetrics, TNM tumor node metastasis
  2. aTwo independent-samples Chi square test was performed
  3. bKruskal–Wallis H test was performed